CTRI/2009/091/000456已完成3 期
A multicentric, single blind, parallel, randomized, phase-III study to evaluate the immunogenicity & safety of BEs combined pentavalent DTwP-rHepB-HIB liquid vaccine administered to 6-8 week old healthy Indian subjects at 6-10-14 weeks EPI schedule in comparison with marketed Shan5 vaccine. - None
Biological E Limited Azamabad Hyderabad AP India0 个研究点目标入组 90 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Intended subjects will be healthy infants between 6 to8 weeks of age that is 42 to 56 days of age,both days inclusive of either gender at the time of 1st vaccination.
- •2.Written informed consent obtained from the subjectâ??s parents or legal representative or guardian.
- •3.Healthy infants with weight greater than or equal to 3300 gms at the time of screening.
- •4.Good clinical condition established by medical history and physical examination with no acute disease, infection or high temperature that is greater then 38.5 degrees C axillary temperature.
- •5.Healthy infants born to mothers seronegative to HBV and HIV as confirmed by laboratory tests on the mother or based on maternity discharge summary.
- •6.Subjects or their mothers not participating in any other trials.
- •7.Infants without contraindications or precautionary circumstances for participating in the trial
- •8.Ability of the subjectâ??s parent or legal representative or guardian to understand and comply with the requirements of the protocol.
排除标准
- •Prior immunization with DTP, Hepatitis-B or HIB vaccine with the exception of BCG &/or oral polio vaccine; Current illness (especially fever) or any acute or congenital illness or disability; Known or suspected allergy to any of the vaccine components;Â Any sign or symptom or systemic dysfunction, especially of the central nervous system (CNS); Known family history of SIDS (Sudden Infant Death Syndrome);Â Inability or unwillingness to abide by the requirements of the protocol;Â Any criteria, which in the opinion of the Investigator, suggests that the subject would not be compliant with the study protocol.
研究者
相似试验
已完成
4 期
A post licensure clinical trial to evaluate the immunogenicity & safety of BE?s combined liquid pentavalent DTwP-rHepB-HIB vaccine (Combe Five) administered to healthy Indian infants in comparison with a licensed Pentavac SD? vaccine available in Indian marketCTRI/2011/04/001681Biological ELimited408
已完成
4 期
A phase IV clinical trial to study the safety and immunogenicity of a single booster dose of BEs Tetanus Toxoid vaccine BETT administered to 18-50 year old healthy Indian adults of either gender.CTRI/2009/091/000539Biological E Limited90
招募中
2 期
A clinical trial to compare the effects of coded Unani research drugs UNIM 001+UNIM003 with Psoralen in the treatment of vitiligoCTRI/2013/12/004215Central Council for Research in Unani Medicine CCRUM New Delhi532
已完成
2 期
A clinical study to evaluate efficacy of a copper containing intrauterine device (Coated Copper- T) in reducing bleeding side effects.CTRI/2016/01/006535HLL Lifecare Limited176
已完成
3 期
Comparison of Efonidipine 40 mg and Chlorthalidone 12.5 mg combination tablets versus Cilnidipine 10 mg and Chlorthalidone 12.5 mg combination tablets in the management of high blood pressure.CTRI/2020/08/027364Zuventus Healthcare Limited240
